Inogen (NASDAQ: INGN) director awarded 28,081 restricted stock units

Rhea-AI Filing Summary

Mora Elizabeth reported acquisition or exercise transactions in this Form 4 filing.

Inogen Inc director Elizabeth Mora received 28,081 shares of common stock as a restricted stock unit award. These RSUs were granted at no cash cost and increase her direct holdings to 107,261 shares. The award will vest after about one year, subject to her continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Mora Elizabeth

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	28,081	$0.00	--

Holdings After Transaction: Common Stock — 107,261 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 28,081 shares Grant price per share: $0.00 per share Shares after transaction: 107,261 shares +1 more

4 metrics

RSU grant size 28,081 shares Restricted stock unit award of common stock

Grant price per share $0.00 per share Equity compensation, no cash paid

Shares after transaction 107,261 shares Director’s direct holdings following the award

Vesting condition Earlier of one-year anniversary or pre-Annual Meeting RSU vesting tied to continued service

Key Terms

restricted stock unit award, vest, Annual Meeting of the Issuer's stockholders, grant, award, or other acquisition

4 terms

restricted stock unit award financial

"The reported shares were acquired pursuant to a restricted stock unit award."

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

vest financial

"the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Annual Meeting of the Issuer's stockholders regulatory

"the day prior to the date of the Annual Meeting of the Issuer's stockholders"

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mora Elizabeth

(Last) (First) (Middle)

C/O INOGEN, INC.

500 CUMMINGS CENTER, SUITE 2800

(Street)

BEVERLY MASSACHUSETTS 01915

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inogen Inc [ INGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		A		28,081(1)	A	$0	107,261	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant.

	/s/ Mary Wright, as Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Inogen (INGN) director Elizabeth Mora report?

Elizabeth Mora reported receiving 28,081 shares of Inogen common stock as a restricted stock unit award. The grant is compensation, not an open-market purchase, and increases her direct ownership position in the company to 107,261 shares after the transaction.

How many Inogen (INGN) shares does Elizabeth Mora hold after this award?

After the restricted stock unit award, Elizabeth Mora holds 107,261 Inogen common shares directly. This total includes the newly granted 28,081 shares, which are structured as RSUs that vest over time rather than immediately tradable common stock at the grant date.

Was cash paid for the Inogen (INGN) shares granted to Elizabeth Mora?

No cash was paid for these shares; the 28,081 Inogen shares were granted at a price per share of $0.00 as a restricted stock unit award. This reflects equity-based compensation rather than a traditional market purchase transaction.

When do Elizabeth Mora’s Inogen (INGN) restricted stock units vest?

The restricted stock unit award will vest on the earlier of the one-year anniversary of the grant date or the day before Inogen’s next Annual Meeting of stockholders. Vesting is conditioned on Mora’s continued service through that vesting date.

Is Elizabeth Mora’s Inogen (INGN) transaction a buy or a grant?

The transaction is a grant of restricted stock units, categorized as a grant, award, or other acquisition. It is not an open-market stock purchase, but equity compensation that converts into shares as the RSUs vest over the specified period.